Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells
Conclusion MixNCH/MK-siRNA nanoparticles could be effective for the treatment of hepatocellular carcinoma.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Gastroenterology | Gene Therapy | Genetics | Hepatocellular Carcinoma | Liver Cancer | Nanotechnology | Pancreas | Pancreatic Cancer | Study